1.39
Schlusskurs vom Vortag:
$1.38
Offen:
$1.32
24-Stunden-Volumen:
24,000
Relative Volume:
0.45
Marktkapitalisierung:
$2.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-2.86M
KGV:
-0.5544
EPS:
-2.5071
Netto-Cashflow:
$-2.57M
1W Leistung:
-2.11%
1M Leistung:
+12.10%
6M Leistung:
-14.20%
1J Leistung:
-53.97%
Bone Biologics Corp Stock (BBLG) Company Profile
Firmenname
Bone Biologics Corp
Sektor
Branche
Telefon
(781) 552-4452
Adresse
2 BURLINGTON WOODS DRIVE,, BURLINGTON
Compare BBLG vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BBLG
Bone Biologics Corp
|
1.39 | 2.50M | 0 | -2.86M | -2.57M | -2.5071 |
|
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Bone Biologics Corp Aktie (BBLG) Neueste Nachrichten
Orthobiologics Devices And Equipment Market Report 2026 Market Outlook Supported By A Forecast 8% CAGR - openPR.com
Bone Biologics Announces $9 Million Private Placement for Spine Fusion Innovation and Clinical Trials Funding 12 - Minichart
Bone Biologics Raises $2.7 Million in Private Placement; Adds $6 Million Upside From Warrants - TradingView
Bone Biologics (BBLG) raises $3M in private placement with up to $6M via warrants - Stock Titan
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why iOThree Shares Are Trading Higher By Around 70%; Here Are 20 Stocks Moving Premarket - Benzinga
What Put Bone Biologics (NASDAQ:BBLG) on Nasdaq Composite Radar? - Kalkine Media
Orthobiologics Market Size to Surge USD 12.55 Billion by 2035 - Precedence Research
Bone Biologics raises $3M now, with up to $6M more from warrants - Stock Titan
Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Yahoo Finance
Demineralized Bone Matrix Market Report 2026 Market Outlook Supported By A Forecast 6.3% CAGR - openPR.com
AMAT Q2 2026 Earnings: EPS Surpasses Estimates But Stock Declines Over 7%Full Year Guidance - dars.gov.et
Executive pay and board elections at Bone Biologics (NASDAQ: BBLG) - Stock Titan
CISS Q3 2025 Earnings: Net Loss of $0.58 Per Share; Stock Trades at $0.61Full Year Guidance - dars.gov.et
ADRMD Stock Price and Chart — OTC:ADRMD - TradingView
Bone Biologics Corp (BBLG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bone Biologics Corp (BBLG) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics Corp (BBLGW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Bone Biologics Corp Warrants (BBLGW) Slide as Selling Pressure Intensifies Near Support LevelsReversal Setup Alerts - dars.gov.et
Bone Biologics Corp (BBLG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bone Biologics Corp (BBLG) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp (BBLG) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp (BBLG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bone Biologics Corp (BBLG) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Bone Biologics Corp (BBLG) Institutional Confidence - TradingKey
Bone Biologics Corp (BBLG) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bone Biologics Corp (BBLGW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Bone Biologics Corp (BBLGW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bone Biologics Corp (BBLGW) Institutional Confidence - TradingKey
Bone Biologics Corp (BBLGW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bone Biologics Corp (BBLGW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Bone Biologics Corp (BBLGW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Bone Biologics Corp (BBLGW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Bone Biologics Corp (BBLGW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beamr Imaging (BMR) Holds Near Support Amid Minimal DeclineAggressive Growth Picks - dars.gov.et
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss Offers Some Relief as Pipeline Progress ContinuesEPS Estimate Trend - newsline.com
BBLG | Bone Biologics Corp Common Insider Trading - Quiver Quantitative
BBLG Q1 2026 Earnings: EPS Beat on Narrower Loss, Stock Dips SlightlyDiluted EPS Report - newsline.com
Bone Biologics Corp (BBLG) Edges Lower Amid Light Trading – Key Support Level in FocusBreadth Thrust - newsline.com
Bone Biologics Corp (BBLG) Edges Lower in Quiet Trading, Holding Above $1.19 SupportBear Flag - newsline.com
Bone Biologics Corp Warrants (BBLGW) Remains Steady at $14.0, Navigating Key Support and Resistance LevelsEnding Diagonal - newsline.com
Bone Biologics Corp Warrants (BBLGW) Surge Over 9%: Key Levels and OutlookOBV Trend Line - newsline.com
From trade-secret suit to Chapter 11: How a San Antonio biotech firm unraveled - San Antonio Express-News
BBLG Q1 2026 Earnings: EPS Beat by 21.9% But No Revenue, Stock Declines 1.6%Earnings Whisper Number - dars.gov.et
Why Marvell Technology Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
Asia Demineralized Bone Matrix Allograft MaterialsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
BBLG Q1 2026 Earnings: Narrower-than-Expected Loss Per ShareRevenue Miss Report - newsline.com
Bone Biologics Corp (BBLG) Edges Higher as Stock Tests Key Technical LevelsATR Stop - newsline.com
Finanzdaten der Bone Biologics Corp-Aktie (BBLG)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):